Insitro partners with Lilly to advance AI-driven metabolic disease treatments
Endpoints News - 09-Oct-2024A collaboration to develop gene-silencing therapies for fatty liver disease
Join the club for FREE to access the whole archive and other member benefits.
A collaboration to develop gene-silencing therapies for fatty liver disease
Funding fuels clinical trials of a lead compound, offering hope for liver disease patients
Blocking cell death pathway rejuvenates livers in mice, offering potential treatment for humans
Company aims to target age-related diseases and liver disease NASH
Scientists injected liver cells into a patient's lymph node, aiming to create a "mini liver"
No resources found!
No blog posts found!